Department of Pharmacy Practice

College of Pharmacy
masthead

John Garofalo

 John Garofalo John Garofalo, PharmD
Associate Director, Clinical Pharmacy Services
Hospital Pharmacy
Department of Pharmacy Practice
Email garofalo@uic.edu
Phone 312-996-7678
Fax 312-413-4146
Office C300 UICMC MC 883
US Mail 1740 West Taylor Street, Room C-300 (MC 883),Chicago, Illinois 60612-7232

Research Interests
Dr. Garofalo's clinical research interests include disorders related to critical care, the gastrointestinal
system and nutritional support. He is also involved with research associated with federally mandated
quality initiatives.

Education
1989 ASHP Accredited Clinical Pharmacy Residency- Chief Resident, University of Illinois Hospital
1988 Doctor of Pharmacy, High Honors, University of Illinois at Chicago, College of Pharmacy, Chicago, IL
1983 Pre-Pharmacy, Dean's List, Elmhurst College, Elmhurst, IL

Current UIC Appointments
1989 to present Clinical Assistant Professor, Department of Pharmacy Practice
2003 to present Associate Director, Clinical Pharmacy Services, Medical Center

Representative Publications
  1. Co-Investigator, "Smart pump technology: an essential component of a comprehensive safe medication administration program in an academic medical center." Crystal Vasquez, John Garofalo. Poster Presentation. The 17th National Evidence-Based Practice Conference: Technological Innovations for Evidence-Based Practice. Iowa City, IA. April 2010.
  2. Garofalo, J., B. Braun’s Outlook 400ES. Pharmacy Purchasing & Products. 2009; 6(11):40-42.
  3. Chan J, Garofalo, J. Inflammatory Bowel Disease. In Smith K, Henyan N, Riche D, (eds): Handbook of Clinical Drug Data. 11th ed. Appleton & Lange, Stamford, CT; 2009.
  4. "Clinical Use of the Modification of Diet in Renal Disease (MDRD) Equation in Dosing of Antimicrobials." S Tokumaru, J Garofalo, D Zadorskaya, P Setlak, W Galanter, MJ Fischer. Poster Presentation. SCCM meeting. Honolulu, HI. January 2008.
  5. Co-Investigator, "Evaluation of current practice in the treatment of severe sepsis and development of practice guidelines for treatment of severe sepsis." R Yeh, J Garofalo, A Donnelly, et al. Poster Presentation. SCCM meeting. Phoenix, AZ. January 2005. Eli Lilly and Company funded $74,880.

Click here to view Dr. Garofalo's on-line CV. PDF logo

Return to faculty list